Patents by Inventor Christel Fenge

Christel Fenge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8697440
    Abstract: The present invention relates to methods and tools for producing large quantities of gamma-carboxylated protein comprising: (i) culturing a cell adapted to express a protein which requires gamma-carboxylation and ?-glutamyl carboxylase in a ratio of at least 10:1, under conditions suitable for expression of both proteins, and (ii) isolating gamma-carboxylated protein.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: April 15, 2014
    Assignee: Medimmune Limited
    Inventors: Christel Fenge, Ann Lövgren, Anders Thelin
  • Publication number: 20110092429
    Abstract: The present invention relates to methods and tools for producing large quantities of gamma-carboxylated protein comprising: (i) culturing a cell adapted to express a protein which requires gamma-carboxylation and ?-glutamyl carboxylase in a ratio of at least 10:1, under conditions suitable for expression of both proteins, and (ii) isolating gamma-carboxylated protein.
    Type: Application
    Filed: November 19, 2010
    Publication date: April 21, 2011
    Inventors: Christel Fenge, Ann Lövgren, Anders Thelin
  • Patent number: 7842477
    Abstract: The present invention relates to methods and tools for producing large quantities of gamma-carboxylated protein comprising: (i) culturing a cell adapted to express a protein which requires gamma-carboxylation and ?-glutamyl carboxylase in a ratio of at least 10:1, under conditions suitable for expression of both proteins, and (ii) isolating gamma-carboxylated protein.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: November 30, 2010
    Assignee: AstraZeneca AB
    Inventors: Christel Fenge, Ann Lövgren, Anders Thelin
  • Publication number: 20050164367
    Abstract: The present invention relates to methods and tools for producing large quantities of gamma-carboxylated protein comprising: (i) culturing a cell adapted to express a protein which requires gamma-carboxylation and ?-glutamyl carboxylase in a ratio of at least 10:1, under conditions suitable for expression of both proteins, and (ii) isolating gamma-carboxylated protein.
    Type: Application
    Filed: October 14, 2004
    Publication date: July 28, 2005
    Applicant: AstraZeneca AB
    Inventors: Christel Fenge, Ann Lovgren, Anders Thelin